Adults
Condition | Dose |
To treat cryptococcal meningitis | 400 mg on the first day and subsequently 200 mg to 400 mg once a day for6 to8 weeks or longer if necessary. In some cases, the dose is increased to 800 mg |
To prevent the recurrence of cryptococcal meningitis | 200 mg once a day until your doctor tells you to |
To treat coccidioidomycosis | 200 mg to 400 mg once a day for 11 to 24 months or longer if necessary. In some cases, the dose is increased to 800 mg |
To treat internal fungal infections caused byCandida | 800 mg on the first day and subsequently 400 mg once a day until your doctor tells you to |
To treat mucosal infections affecting the oral mucosa, throat, or associated with dental prostheses | 200 mg to 400 mg on the first day and subsequently 100 mg to 200 mg once a day until your doctor tells you to |
To treat mucosal candidiasis – the dose depends on the location of the infection | 50 mg to 400 mg once a day for7 to30 days until your doctor tells you to |
To prevent the recurrence of mucosal infections affecting the oral mucosa and throat | 100 mg to 200 mg once a day, or 200 mg three times a week, as long as you continue to be at risk of developing an infection |
To prevent the development of an infection caused byCandida(if your immune system is weakened and does not function properly) | 200 mg to 400 mg once a day as long as you continue to be at risk of developing an infection |
Adolescents aged12 to17 years
Follow the doseindicatedby your doctor (the adult dose or the pediatric dose).
Children up to 11 years
The maximum daily dose forchildrenis 400 mg per day.
The dose will be based on the child's weight in kilograms.
Condition | Daily dose |
Mucosal candidiasis and throat infections caused byCandida– the dose and duration of treatment depend on the severity of the infection and its location | 3 mg per kilogram of body weight once a day (the first day may be 6 mg per kilogram of body weight) |
Cryptococcal meningitis or internal fungal infections caused byCandida | 6 mg to 12 mg per kilogram of body weight once a day |
To prevent the recurrence of cryptococcal meningitis | 6mg per kilogram of body weight once a day |
To prevent the child from contracting an infection caused byCandida(if your immune system does not function properly) | 3 mg to 12 mg per kilogram of body weight once a day |
Use in children 0 to4 weeks
Use in children aged 3 to 4 weeks:
Use in children under 2 weeks:
Geriatric patients
The usual adult dose, unless you have kidney problems.
Patients with kidney disease
Your doctor may change your dose, depending on how well your kidneys are functioning.
Receiving more Fluconazol B. Braun than prescribed
If you are concerned that you may have been given too much Fluconazol B.Braun, consult your doctor or nurse immediately. Symptoms of a possible overdose may include hearing, seeing, feeling, and thinking things that are not real (hallucinations and paranoid behavior).
Missing a dose of Fluconazol B. Braun
Since this medication will be administered under strict medical supervision, it is unlikely that a dose will be missed. However, if you think you may have missed a dose, consult your doctor or pharmacist.
If you have any other questions about the use of thismedication, ask your doctor,pharmacist, or nurse.
Like all medicines, Fluconazol B. Braun may cause side effects, although not everyone will experience them.
Stop usingFluconazol B.Braunand seek immediate medical attention if you notice any of the following symptoms:
Some people developallergic reactions, although severe allergic reactions are rare (they can affect up to 1 in 1000 patients). If any of the following symptoms appear,inform your doctor immediately.
Fluconazol B. Braun may affect your liver.The signs that indicate liver problems are:
If you experience any of these symptoms, stop using Fluconazol B.Braun andinform your doctor immediately.
Other side effects
In addition, if you consider that any of the side effects you are experiencing are severe or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
Frequent side effects that may affect up to 1 in 10 patients:
Rare side effects that may affect up to1 in 100 patients:
Rare side effects that may affect up to 1 in 1000 patients:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect not mentioned in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:http://www.notificaRAM.es.
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the label and in the box after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C. Do not freeze.
This medication must be used immediately after opening the container.
Use only this medication if the solution is transparent and does not contain visible particles. Do not use if the bottle is damaged.
This medication is for single use only.
Once opened, the unused infusion must be discarded.
Medications should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. By doing so, you will help protect the environment.
Composition of Fluconazole B. Braun
Appearance of the productand contents of the package
Fluconazole B. Braun is a transparent colorless solution that contains the ingredients mentioned above in water.
It is presentedin polyethylene bottles of 50 ml, 100 ml or 200 ml.
Packaging formats:10, 20 or 50 bottles.
Only somepackage sizes may be commercially available.
Holder of the marketing authorization and responsible for manufacturing
B. Braun Melsungen AG
Carl-Braun-Straße 1
34212 Melsungen
Postal address:
34209 Melsungen
Phone: +49-5661-71-0
Fax: +49-5661-71-45 67
Manufacturer:
B. Braun Medical S.A.
Carretera de Terrassa, 121
08191 Rubí (Barcelona)
Spain
This medicinehas beenauthorized in the member statesof the European Economic Areaand in the United Kingdom (Northern Ireland)with the following names:
Germany | Fluconazole B. Braun 2 mg/ml Infusionslösung |
Austria | Fluconazole B. Braun 2 mg/ml Infusionslösung |
Belgium | Fluconazole B. Braun 2 mg/ml oplossing voor infusie |
Denmark | Fluconazole B.Braun |
Slovenia | Flukonazol B. Braun 2 mg/ml raztopina za infudiranje |
Spain | Fluconazole B. Braun 2 mg/ml solución para perfusión EFG |
Finland | Fluconazole B. Braun 2 mg/ml infuusioneste, liuos |
Greece | Fluconazole B. Braun 2 mg/ml δι?λυμα προς ?γχυση |
Ireland | Fluconazole 2 mg/ml solution for infusion |
Italy | Fluconazolo B. Braun 2 mg/mlsoluzione per infusione |
Luxembourg | Fluconazol B. Braun 2 mg/ml Infusionslösung |
Norway | Fluconazol B. Braun 2 mg/ml infusjonsvæske, oppløsning |
Poland | Fluconazole B. Braun 2 mg/ml, roztwór do infuzji |
United Kingdom (Northern Ireland) | Fluconazole 2 mg/ml solution for infusion |
Sweden | Fluconazole B. Braun 2 mg/ml infusionsvätska, lösning |
Last review date of thisleaflet: 02/2024
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS):http://www.aemps.gob.es/
This information is intended solely for healthcare professionals:
Intravenous infusion should be administered at a rate that does not exceed10 ml/min. Fluconazole B. Braun is formulated with a 0.9% sodium chloride solution; each 200 mg (100 ml bottle) contains 15 mmol of Na+and Cl-. Due to the fact that Fluconazole B. Braun is available as a diluted sodium chloride solution,in patients with sodium or fluid restrictions, the rate of fluid administration should be taken into account.
Fluconazole B. Braun 2 mg/ml is compatible with the following infusion fluids:
a)Glucose infusion solution 200 mg/ml (if available)
b)Solution for infusion of Ringer's solution
c) Hartmann's solution, lactate Ringer's solution(if available)
d)Potassium chloride solution 20 mEq/l in glucose 50 mg/ml(if available)
e) Sodium bicarbonate solution for infusion 84 mg/ml (8.4%)(if available)
f) Sodium chloride solution 9 mg/ml (0.9%)
g) Isofundin infusion solution(if available)
Fluconazole can be infused through an existing route along with one of the above-mentioned fluids. Although no specific incompatibilities have been observed, it is not recommended to mix Fluconazole B.Braun with other medications before infusion.
The infusion solution is for single use only.
Valid period after opening the package:
The medicine should be used immediately after the first opening of the package.
Valid period after mixing according to instructions:
Chemical stability has been demonstrated at 25 °C for 72 hours
From a microbiological point of view, the dilutions should be used immediately. If not used immediately, the storage times and conditions in use are the responsibility of the user and should not normally exceed 24 hours at a temperature of 2 °C to 8 °C, unless the dilution has been prepared in facilities with controlled and validated aseptic conditions.
The dilution should be prepared in aseptic conditions. Before administration, the solution should be inspected to check for visible particles or discoloration. Only the solution should be used if it is transparent and free of particles.
The elimination of unused medicine and all materials that have come into contact with it should be carried out in accordance with local regulations.
If you want the complete information on this medicine, consult the product technical file.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.